mAbs

Revolutionizing mAb Development: How Cutting-Edge Technology Enhances Monitoring of Critical Quality Attributes

[Adobe Stock] The monoclonal antibodies (mAbs) market is booming, worth over $330 billion and expected to exceed that by 2030. ... Read more